Entry Detail



General Information

Database ID:exR0006368
RNA Name:HLA-A
RNA Type:mRNA
Chromosome:chr6
Starnd:+
Coordinate:
Start Site(bp):29941260End Site(bp):29945884
External Links:ENSG00000206503



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACHE
chr7
100889994
100896974
-
ACTR3
chr2
113890063
113962596
+
ABCD1
chrX
153724856
153744755
+
AGGF1
chr5
77029251
77065234
+
ABHD2
chr15
89087459
89202355
+
AC005258.1
chr19
2269525
2341172
+
AKR1A1
chr1
45550543
45570049
+
ACO2
chr22
41469117
41528989
+
ACTB
chr7
5527148
5563784
-
ACTC1
chr15
34790230
34795549
-
ADCY1
chr7
45574140
45723116
+
AFG3L2
chr18
12328944
12377227
-
AL162417.1
chr9
133098121
133163914
-
ALDOA
chr16
30064164
30070457
+
AFTPH
chr2
64524305
64593005
+
AL807752.6
chr9
137031241
137040436
-
AC092073.1
chr19
34396315
34409364
+
AC004922.1
chr7
99325879
99394653
+
AGPAT1
chr6
32168212
32178096
-
AL022238.4
chr22
40346529
40410054
+
AHCY
chr20
34280268
34311802
-
AC007192.1
chr19
18153158
18178117
+
AHCYL1
chr1
109984765
110023742
+
AL136295.5
chr14
24147548
24166452
+
ACIN1
chr14
23058564
23095614
-
AL136454.1
chr1
192716132
192716653
+
AC120057.2
chr17
7240427
7244635
-
AGO1
chr1
35869808
35930532
+
AC027644.4
chr7
66628958
66811189
+
AC068547.1
chr2
151802651
151973949
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-4680-5p
chr10
110898094
110898116
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007952.4
chr17
19112000
19112636
-
AC008443.1
chr5
181246507
181272167
+
AC009686.2
chr8
80032724
80033300
-
AC010327.5
chr19
55216660
55221616
+
AC016876.2
chr17
7581964
7584086
-
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC084824.5
chr12
32736930
32737660
-
AC245884.11
chr19
54308915
54337168
-
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.